Table 2.
Detail of the studies included in the review
First author | Year | Country | Time frame of SQ | Diagnosis | Clinician | Location/setting | Total | Patient age (Mean, SD) | Patient Sex (M:F) | Mean QS (/ 9) |
---|---|---|---|---|---|---|---|---|---|---|
Amro [18] | 2016 | USA | 12 months | End-stage renal failure | Nephrologists | Dialysis unit/hospital | 201 | 66 | 105:46 | 6.5 |
Barnes [35] | 2008 | UK | 12 months | Heart failure | General practitioners | General practice | 231 | 77 (71–82)c | 120:111 | 4.5h |
Carmena [19] | 2016 | Spain | 12 months | End stage renal failure | Medical staff | HD unit | 49 | NR | NR | 5.0h |
Cohen [20] | 2010 | USA | 6 months | End-stage renal failure | Nephrologists | HD 5 units | 450b | 61 (17) | 285:225 | 8.0 |
Da Silva [40] | 2013 | UK | 12 months | End-stage renal failure | Nurses and Nephrologists | HD units | 344 | 63.6 (15.5) | 221:123 | 6.5 |
Fenning [30] | 2012 | UK | 6–12 months | Heart failure | Clinical team | Hospital cardiology unit | 172 | 66 | 105:67 | 9.0 |
Feyi [21] | 2015 | UK | 6–12 months | End-stage renal failure | Consultant renal physician, consultant in palliative medicine and renal nursing staff | Dialysis unit/hospital | 178 | NR | 48:22 | 6.0 |
Gardiner [36] | 2013 | UK | 12 months | Any diagnosis | Doctor (Nursing Staff) | Acute hospital | 297 | 78d | 136:161 | 5.5 |
Reida [43] | 2012 | UK | during this admission | Any diagnosis | Nursing staff | 5 wards and 2 specialist palliative care beds | 6703 | 80.6 (11.2) | 20:40 (partial) | 5.0h |
Gopinathana [31] | 2016 | India | 6 months | End-stage renal failure | Principal investigator | Tertiary care hospital | 39 | NR | NR | 5.0h |
Haga [15] | 2012 | UK | 6–12 months | Heart failure | Specialist heart failure nurse | Hospital community-based patients | 138 | 77 (10) | 91:47 | 7.5 |
Halbea [22] | 2015 | Germany | 12 months | Cancer | Medical staff | Haematology and oncology outpatient clinic | 651 | NR | NR | 5.5 |
Hamano [23] | 2015 | Japan | 7 days | Cancer | Palliative care physicians’ | 16 palliative care units, 19 hospital-based palliative care teams, and 23 home-based palliative care services | 2361 | 69.1 (12.6) | 1358:1003 | 6.5 |
Johnson [37] | 2012 | UK | 12 months | Heart failure | Heart failure nurse | Cardiology palliative care team | 126 | 78 (10.7)e | 78:47 | 5.5 |
Khana [44] | 2014 | USA | 6 months | Any diagnosis | Intensivists | Medical intensive care unit | 500 | NR | NR | 3.0h |
Lefkowitsa [38] | 2015 | USA | 12 months | Cancer | Physicians, advanced practice providers, 4 nurses | Academic institution | 263 | NR | 0:263 | 5.5 |
Lilley [39] | 2016 | USA | 12 month | Any diagnosis | Surgeons | Tertiary care academic hospital | 163 | NR | 78:85 | 7.5 |
Moroni [25] | 2014 | Italy | 12 months | Cancer | General practitioners | GPs | 231 | 70.2 (0.9) | 117:114 | 8.5 |
Moss [27] | 2008 | USA | 12 months | End-stage renal failure | Nurse practitioner | 3 HD units | 147 | 66.4 (14.8) | NR | 7.5 |
Moss [26] | 2010 | USA | 12 months | Cancer | Oncologists | Academic cancer centre | 826 | 60 (13) | 126:727 | 7.5 |
O'Callaghan [28] | 2014 | New Zealand | 6 months | Any diagnosis | Two expert palliative care clinicians (doctor and a nurse) | Tertiary New Zealand teaching hospital | 501 | NR | 47:50g | 7.0 |
Pang [29] | 2013 | Hong Kong | 12 months | End-stage renal failure | Nephrologists | Dialysis centre | 367 | 60.2 (12.3) | 204:163 | 6.5 |
Southa [32] | 2011 | UK | 6–12 months | COPD | Clinician | Nurse-led unit for COPD | 199 | 70 (37–93)f | 92:107 | 4.5h |
Strouta [42] | 2016 | USA | 30 days | Sepsis | Emergency physicians | Emergency Dept | 330 | NR | 181:149 | 4.5h |
Thiagarajan [33] | 2012 | UK | 12 months | Any diagnosis | Doctor, nurse, physiotherapist and occupational therapist | Inpatient of an acute/geriatric medical ward | 130 | 80.7 (18–104)f | 55:75 | 7.5 |
Vicka [34] | 2015 | USA | 12 months | Cancer | Oncology clinicians | Cancer centre | 4617 | NR | NR | 3.0h |
aAbstract
bOut of a total sample of 512, 450 had a response to the SQ
cMedian (IQR)
dMedian
eMean number of days (IQR)
fRange
gIncluded one transgender and one unknown
hExcluded for sensitivity analysis
COPD chronic obstructive pulmonary disease, NR not reported